Mapping Alzheimer's disease heterogeneity with molecular imaging biomarkers.

Saved in:
Bibliographic Details
Title: Mapping Alzheimer's disease heterogeneity with molecular imaging biomarkers.
Authors: Harput E; Laboratory of Neuroimaging and Innovative Molecular Tracers (NIMTlab), Geneva University Neurocentre and Faculty of Medicine, University of Geneva, Geneva, Switzerland., Boccalini C; Laboratory of Neuroimaging and Innovative Molecular Tracers (NIMTlab), Geneva University Neurocentre and Faculty of Medicine, University of Geneva, Geneva, Switzerland., Mathoux G; Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospitals, Geneva, Switzerland., Prior JO; Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Lausanne, Switzerland., Testart N; Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Lausanne, Switzerland., Jreige M; Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Lausanne, Switzerland., Garibotto V; Laboratory of Neuroimaging and Innovative Molecular Tracers (NIMTlab), Geneva University Neurocentre and Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospitals, Geneva, Switzerland.; CIBM, Centre for Biomedical Imaging, University of Geneva, Geneva, Switzerland.
Source: European journal of clinical investigation [Eur J Clin Invest] 2026 Jan; Vol. 56 (1), pp. e70163. Date of Electronic Publication: 2025 Dec 17.
Publication Type: Journal Article; Review
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 0245331 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2362 (Electronic) Linking ISSN: 00142972 NLM ISO Abbreviation: Eur J Clin Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1365-2362
DOI:10.1111/eci.70163